Corrigendum to “adjuvant Immunotherapy in Older Patients with Stage III and Resected Stage IV Melanoma: Toxicity and Recurrence-Free Survival Outcomes from the Dutch Melanoma Treatment Registry” [eur. J. Cancer 212, 2024, 115056]
European Journal of Cancer(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要